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Nasopharyngeal swabs were taken from volunteers attending a general medical practice and a general
hospital in Lancaster, UK, and at Lancaster University, in the winter of 2014–2015. 51 swabs were selected
based on high RNA yield and allocated to deep sequencing pools as follows: patients with chronic
obstructive pulmonary disease; asthmatics; adults with no respiratory symptoms; adults with feverish
respiratory symptoms; adults with respiratory symptoms and presence of antibodies against inﬂuenza C;
paediatric patients with respiratory symptoms (2 pools); adults with inﬂuenza C infection (2 pools), giving a
total of 9 pools. Illumina sequencing was performed, with data yields per pool in the range of 345.6
megabases to 14 gigabases after removal of reads aligning to the human genome. The data were deposited
in the Sequence Read Archive at NCBI, and constitute a resource for study of the viral, bacterial and fungal
metagenome of the human nasopharynx in healthy and diseased states and comparison with other
metagenomic studies on the human respiratory tract.
Design Type(s) observation design • disease state design • parallel group design
Measurement Type(s) metagenomics analysis
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Background & Summary
Respiratory infectious disease is a major cause of morbidity and mortality in the elderly, infants, the
immune-compromised and those with underlying serious pulmonary conditions such as asthma or cystic
ﬁbrosis. It is also a source of considerable economic damage through working days lost to illness in
adults (ref. 1). Fungi, viruses and bacteria can all cause respiratory infections, but aside from a handful of
high proﬁle pathogens such as inﬂuenza A virus, Pneumocystis carinii, respiratory syncytial virus and
Streptococcus, the problem of respiratory infectious disease diagnosis, treatment and prevention remains
neglected.
The sheer diversity of microbes causing respiratory infections that are indistinguishable on clinical
examination, means that the vast majority of patients receive only a generic diagnosis of coryza or
pharyngitis. Active identiﬁcation of a causative agent is usually only performed in the event of the illness
progressing to severe bronchitis or pneumonia. Despite the highly selective nature of diagnostic results
obtained in this way, they offer many important insights. For instance, the WHO tracks the progress of
inﬂuenza across the world (ref. 2) using percentages of samples testing positive for inﬂuenza viruses A/
H1N1, A/H3N2 and B. Cumulatively, such diagnostic samples may demonstrate trends in respiratory
illness over several years. Nickbakhsh, et al. (ref. 3) tested for 11 virus groups in >60,000 samples
collected from >40,000 patients in the west of Scotland from 2005 to 2013, revealing extensive co-
infections and a general increase in the respiratory viral load in the population, especially in infants,
which remains unexplained.
Deep sequencing, which produces a metagenome reﬂecting the total microbial genetic content in a
sample, offers an alternative to such highly targeted approaches, but is only just beginning to enter the
routine diagnostic pipeline (ref. 4–6). Nevertheless, accumulation of human respiratory tract
metagenomes from research projects is well underway, providing a resource for the generation of a
comprehensive proﬁle of the respiratory microbiome in both health and disease. Within the Sequence
Read Archive (SRA), the tag ‘human nasopharyngeal metagenome’ identiﬁes 41 BioProject entries as
of 30th August 2017, including that reported here. Within this group of datasets, there are upper
respiratory tract metagenomes associated with inﬂuenza, respiratory syncytial virus, allergy,
intubation, asthma, macular degeneration, oesophageal reﬂux, rhinosinusitis and Parkinsonism as
well as samples taken from healthy volunteers. Our project (ref. 7) initially focussed on the prevalence
and severity of inﬂuenza C infection in Lancaster, UK, during the winter of 2014–2015. We performed
Ilumina deep sequencing on 9 patient pools (Data Citations 1–9), as detailed in Table 1. Two of our 9
sequencing pools (Data Citations 8, 9) were from individuals diagnosed with inﬂuenza C infection via
quantitative RT-PCR, from one of which we could partially assemble (ref. 7) the genome of a novel
strain of inﬂuenza C, designated C/Lancaster/1/2015 (Data Citations 10–12). Within other sequencing
pools we also detected the complete genomes of novel strains of human rhinovirus A22
(ref. 8), human papillomavirus 23 (ref. 9) and human papillomavirus 20 (ref. 10) (Data Citations
13–15).
Figure 1 summarises our clinical workﬂow. From the 148 samples taken, 51 were prioritised for
allocation to the 9 sequence pools, based on high yield of RNA and/or clinical phenotype. Our interest in
inﬂuenza C is reﬂected in the decision to devote 2 of our 9 sequencing pools to single individuals positive
for inﬂuenza C by reverse transcription polymerase chain reaction (RT-PCR), one of whom was
extensively sequenced (14 Gb). Paediatric coryza was similarly also prioritised (ref. 11) with two pools of
2 and 3 individuals respectively (Data Citations 1, 2). Figure 2 summarises how deep sequencing reads
were processed. The raw deep sequencing output was ﬁrst trimmed of adapter and other extraneous
sequences, then groomed to remove reads of low quality score. To avoid the potential ethical
complication of sequence from the genomes of the volunteers being present in the sample, three versions
of the human genome were used to screen out reads of human origin. It should be noted, however, that
Set BioSample Source Clinical pool size Experiment SRA Run Bases
A SAMN05954283 Paediatric, Low RNA Coryza 3 SRX2310763 SRS1768710 SRR4733499 1.1 G
B SAMN05954284 Paediatric, High
RNA
Coryza 2 SRX2310764 SRS1768711 SRR4733500 964.8 M
C SAMN05954285 Adult, High ﬂuC IgG Coryza 10 SRX2310765 SRS1768712 SRR4733501 345.6 M
D SAMN05954286 Adult Fever 8 SRX2310766 SRS1768713 SRR4733502 714.3 M
E SAMN05954287 Adult Asymptomatic 10 SRX2310759 SRS1768706 SRR4733495 909.7 M
F SAMN05954288 Adult Asthmatic 10 SRX2310760 SRS1768707 SRR4733496 477.5 M
G SAMN05954289 Adult COPD 6 SRX2310761 SRS1768708 SRR4733497 1.5 G
H SAMN05954290 adult Inﬂuenza C positive 1 SRX2310762 SRS1768709 SRR4733498 14 G
I SAMN05954291 Adult Inﬂuenza C positive 1 SRX2310758 SRS1768705 SRR4733494 1.2 G
Table 1. Deep sequencing pools A-I, their sources and references. The number of bases per sequencing
pool is given in gigabases (G) or megabases (M) for those pools generating less than 1G after removal of reads
of human genome origin. COPD: chronic obstructive pulmonary disease. IgG: immunoglobulin G.
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we have not attempted to remove any of the known common bacterial contaminants of deep sequencing
reactions (ref. 12).
Since we performed deep sequencing on extracted RNA (see Methods), reads are expected to be
greatly biased towards expressed regions. Therefore, although we have previously used the data to derive
3 complete short viral genomes (ref. 8–10), detectable genomes of cellular microbes are more likely to be
fragmentary. Nevertheless, the dataset may be used for the discovery of further novel viruses, or for
comparative studies of the whole virome or bacteriome between the 7 different clinical states deﬁned in
the 9 samples. Some of the samples may be compared with other microbiome depositions in the SRA, for
instance with BioProject PRJNA310124 (Data Citation 16) on asthma in children (ref. 13). The smaller
sequence read sets, for instance SRX2310765 (Data Citation 3) which contains 346Mb of sequence, are
suitable for use as training data for the bioinformatics tools used in metagenomics.
Figure 1. Clinical ﬂowchart. From 148 nasopharyngeal swabs, 51 were chosen for allocation to 7 symptom
groups, of which 2 were divided into two separate runs, making a total of 9 deep sequencing pools.
Figure 2. Read processing ﬂowchart. The raw reads were cleaned and then subjected to sequential alignments
to 3 versions of the human genome, with mapped reads discarded at each stage. The software used at each stage
is shown.
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Methods
Ethics
Ethical approval was granted by the UK National Research Ethics Service (NRES), reference 14/LO/1634,
Integrated Research Application System (IRAS) Project 147631. The project was registered with the
National Institute of Health Research (NIHR), UK, as part of the NIHR Clinical Research Network
(UKCRN) Portfolio, ID 17799. All methods were carried out in accordance with the relevant guidelines
and regulations. Informed consent was obtained from all volunteers of 18 years and older. For those
under 18 years, informed parental consent was obtained, together with supervised assent of the volunteer.
Patient recruitment & sample processing
Participants were approached in 3 locations in Lancaster, UK, (54.05 °N 2.80 °W) from November 2014 to
May 2015: 1) Lancaster University, 2) a general medical practice, 3) hospital clinics. After informed
consent was given, patients were allocated to a clinical category (Fig. 1). Nasopharyngeal swabs
(MW951SENT, Medical Wire) were brushed over the rear wall of the nasopharynx of patients, and the
tips then snapped off directly into Sigma Virocult medium.
RNA was extracted from the nasopharyngeal swabs using a MagMAX Viral RNA Isolation Kit
(Ambion). cDNA was prepared using a High-Capacity RNA-to-cDNA Kit (Applied Biosystems, Life
Technologies) and a Veriti Thermal Cycler (Applied Biosystems, Life Technologies). The samples were
incubated at 37 °C for 60 min, before stopping the reaction at 95 °C for 5 min and then holding at 4 °C.
Storage of completed reactions was at −20 °C. After selection of a subset of samples (Fig. 1), deep
sequencing was performed using an Illumina Nextera XT library kit in 2 × 126 bp format on the Illumina
HiSeq2500 system.
Processing of raw deep sequencing data for quality control and to remove reads of human
genome origin
Quality of Illumina deep sequencing reads was assessed using FastQC (see Technical Validation). Reads
were then trimmed of adapters and other non-genomic elements using CutAdapt 1.1 (ref. 14) (https://
pypi.python.org/pypi/cutadapt), fastq-mcf 0.11.3 (ref. 15) (https://expressionanalysis.github.io/ea-utils),
and trim_galore (http://www.bioinformatics.babraham.ac.uk/projects/trim_galore/), within the Read_-
cleaner pipeline (Gatherer, unpublished, see Code Availability). Reads of less than 25 bases after
trimming were discarded.
Read_cleaner implements the following commands:
● fastx_clipper -a ADAPTOR_SEQ -l 25 -n -v -M 5 -i INPUT_FILE -o TEMP_FILE
● trim_galore --length 25 --adapter ADAPTOR_SEQ --stringency 5 TEMP_FILE
● fastq-mcf adapters.fa TEMP_FILE -l 25 -o OUTPUT_FILE
cycling fastx_clipper and and trim_galore (which itself pipelines CutAdapt) over a set of common
adaptor sequences, passing the output of each iteration to a temporary ﬁle, followed by application of
fastq-mcf, which takes all the adapters in a single ﬁle. Minimum read length is speciﬁed as 25 for each of
the 3 commands, but this is an operator-entered variable in Read_cleaner.
Ethical approval required that no genetic material remain within the samples which could enable
identiﬁcation of patients. Therefore, human genome and transcriptome sequences were removed by
iterative alignment onto the NCBI, Ensembl and UCSC human iGenomes (http://support.illumina.com/
sequencing/sequencing_software/igenome.html), ﬁrst using bowtie 1.1.1 (ref. 16) (http://bowtie-bio.
sourceforge.net/index.shtml), then BWA 0.7.12-r1039 (ref. 17) (http://bio-bwa.sourceforge.net). Follow-
ing each alignment, extraction of unaligned reads was achieved using samtools 0.1.19 (ref. 18) (http://
samtools.sourceforge.net) and the next alignment commenced. Bowtie, BWA and samtools were co-
ordinated using the Vanator pipeline (ref. 19).
Vanator implements the following commands for bowtie and BWA:
● bwa aln GENOME READS>SAI_INDEX
● bwa samse GENOME SAI_INDEX READS>SAM
● bowtie -S -p 8 GENOME READS SAM
● samtools view -S SAM -b -o BAM
● samtools sort BAM BAM_FILE
● samtools index BAM
● bam2fastq --no-aligned --force --strict -o READS BAM
cycling over the three reference human genomes, each time retrieving the unaligned reads using
bam2fastq.
Quality improvements were checked, again using FastQC (see Technical Validation).
Identiﬁcation of potential bacterial contaminants in the sequence pools
Potential contaminating genomes (produced by the presence of non-metagenome DNA contaminants in
sequencing reagents) were hypothesised by reference to Salter et al. (ref. 12), and a representative
screening set was selected as follows: NC010725 Methylobacterium populi BJ001; NC009485
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Bradyrhizobium sp. BTAi1; NC014323 Herbaspirillum seropedicae SmR1; NC022438 Leifsonia xyli
subsp. cynodontis DSM 46306; NC015675 Mesorhizobium opportunistum WSM2075; NC007794
Novosphingobium aromaticivorans DSM 12444; NC008313 Ralstonia eutropha H16 chromosome 1;
NZCP009571 Sphingomonas taxi strain ATCC 55669; NZCP010409 Xanthomonas sacchari strain R1.
An assessment of the relative contribution of such contaminants was produced by aligning each
sequence pool onto the genomes listed above using bowtie 1.1.1 (ref. 16) (http://bowtie-bio.sourceforge.
net/index.shtml). However, no further action was taken to remove reads corresponding to these
contaminants, or related species, and they remain in the data (see Technical Validation).
Code availability
The unpublished Read_cleaner pipeline is freely available under CC-BY license (Data Citation 17) along
with instructions for its use. Vanator (ref. 19) is available at https://sourceforge.net/projects/vanator-cvr.
Data Records
The primary data discussed in this paper is the Illumina deep sequencing output available in Data
Citations 1–9. The data format of the deep sequencing output is FASTQ (ref. 20), which adds sequencing
quality data to the well-established FASTA nucleic acid sequence format (ref. 21). Viral genome
sequences derived from the deep sequencing output by assembly (see Methods) are given in Data
Citations 10–15. These are in GenBank format.
Table 1 cross-references the SRA BioSample, Experiment, Accession and Run references against the
clinical sources and other data on each sequencing pool. These different accessions provide alternative
access points to the data within SRA. They are intended to operate in a hierarchical manner, allowing for
instance several sequencing ‘Runs’ to be derived from each ‘Experiment’, and several ‘Experiments’ to be
performed on a single ‘BioSample’, and so on. In our work, the hierarchy is sparse, in that each ‘Sample’
was treated as a separate ‘Experiment’, and only one deep sequencing ‘Run’ performed on each.
Table 2 gives the proportion of reads aligning to the top two contaminants of each sequencing pool. In
all pools, Methylobacterium populi is the most common contaminant, with more than 3% of reads in all
pools except F, and up to 21% of reads in pool A, and the second most common is Ralstonia eutropha,
with under 0.7% of reads in all pools. Other contaminants total 0.1 to 1.2% of reads.
Technical Validation
Deep sequencing read technical quality
FastQC (https://www.bioinformatics.babraham.ac.uk/projects/fastqc/) was used to check the quality of
the Illumina sequencing reads, both in their raw state and after the cleaning processes described above in
Methods. FastQC output is deposited in Data Citation 18.
Deep sequencing reagent contaminants
Alignments of each sequencing pool to a set of representative common reagent contaminant
genomes (ref. 12) was performed using bowtie 1.1.1 (ref. 16) (http://bowtie-bio.sourceforge.net/index.
shtml). The BAM ﬁles, their BAI indexes and the contaminant reference genomes are deposited in Data
Citation 19.
NC010725 M.populi NC008313 R. eutropha Others
Set Proportion (%) Proportion (%) Proportion (%)
A 21 0.3 0.6
B 14 0.2 0.5
C 3.0 0.1 0.1
D 20 0.4 0.7
E 12 0.6 1.2
F 0.9 0.1 0.2
G 9.1 0.7 1.0
H 16 0.2 0.5
I 12 0.2 0.5
Table 2. Proportion of common reagent contaminants per sequencing pool. The pools are labelled A-I
as in Table 1. Proportions are calculated as number of reads aligning to a representative set of typical
contaminants12, per total number of reads in that pool. M.populi: Methylobacterium populi; R.eutropha:
Ralstonia eutropha. See Data Citation 19 for further details.
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